An essential role of angiotensin II receptor type 1a in recipient kidney, not in transplanted peripheral blood leukocytes, in progressive immune-mediated renal injury
Y. Hisada et al., An essential role of angiotensin II receptor type 1a in recipient kidney, not in transplanted peripheral blood leukocytes, in progressive immune-mediated renal injury, LAB INV, 81(9), 2001, pp. 1243-1251
Despite an intensive effort of elucidating the pathogenic role of angiotens
in II (All) in immune-mediated renal injury, the precise mechanisms are poo
rly understood. In the present study, we examined the site of All action, p
eripheral blood leukocytes or resident renal cells, in immune-mediated rena
l injury using All type 1a receptor (AT1a)-deficient homozygous (AT1a -/-)
mice and wild-type (AT1a +/+) mice. The AT1a -/- mice showed delayed-type h
ypersensitivity similar to that of the AT1a +/+ mice, suggesting that the l
ack of AT1a does not impair a Th1-type cellular immune response of peripher
al blood leukocytes involved in immune-mediated renal injury. We then gener
ated the radiation bone marrow chimera mice, WA and AW, which have transpla
nted peripheral blood leukocytes from the AT1a +/+ and AT1a -/- mice into t
he AT1a -/- and AT1a +/+ mice, respectively. As controls, WW and AA, the AT
1a +/+ and AT1a -/- mice given bone marrow cells from the AT1a +/+ and AT1a
-/- mice, respectively, were generated. Seven days after induction of anti
glomerular basement membrane nephritis, glomerulosclerosis observed in the
WW mice was markedly ameliorated in the WA mice, but not in the AW mice. In
addition, the recruitment of monocytes/macrophages and the expressions of
monocyte chemoattractant protein-1 and intercellular adhesion molecule-1 in
the glomeruli of the AW and WW mice was evident, but such significant phen
otypes were not seen in the WA and AA mice, showing a marked amelioration o
f renal injury dependent on the host AT1a genotype. These results demonstra
te an essential role of AT1a in intrinsic renal cells for progressive immun
e-mediated renal injury and indicate a beneficial effect of blocking the re
nin-angiotensin system in the treatment of such diseases.